Summary:
Segal Trials is currently conducting a clinical research study evaluating the safety and effectiveness of an investigational medication for subjects with schizophrenia.
(2 visits)
Qualified Participants Must:
• Be between the ages of 18-65
•
Be diagnosed with Schizophrenia and currently on brexpiprazole
Qualified Participants May Receive:
- Study Related Exams & Lab Work at No Cost
- Investigational Medication
- Complimentary Transportation
- Compensation up to $100